REFERENCES

1. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-3.

2. Hensley ML, Ford JM. Imatinib treatment: specific issues related to safety, fertility, and pregnancy. Semin Hematol 2003;40:21-5.

3. Slade R, James DK. Pregnancy and maternal malignant hematological disorders. In: Turner TL, editor. Perinatal Hematological Problems. Chichester: John Wiley and Sons Ltd; 1991. pp. 23-38.

4. Rothman LA, Cohen CJ, Astarloa J. Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. Am J Obstet Gynecol 1973;116:1023-34.

5. Lichtman M, Liesveld J. Acute myelogenous leukemia. Williams Hematology. 6th ed. New York: McGraw-Hill; 2001. pp. 1047-84.

6. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med 1988;148:2058-64.

7. Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet Gynecol Clin North Am 1998;25:323-9.

8. Zuazu J, Julia A, Sierra J, Valentin MG, Coma A, Sanz MA, Batlle J, Flores A. Pregnancy outcome in hematologic malignancies. Cancer 1991;67:703-9.

9. Ault P, Kantarjian H, O'Brien S, Faderal S, Beran M, Rios M, Koller C, Giles F, Keating M, Talpazand M, Cortes J. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 2006;24:1204-8.

10. Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G, Apperley JF. The effects of imatinib on pregnancy outcome. Blood 2008;111:5505-8.

11. Cortes J, O'Brien S, Ault P, Borthakur G, Jabbour E, Bradley-Garelik B, Debreczeni K, Yang D, Liu D, Kantarjian H. Pregnancy outcomes among patients with chronic myeloid leukemia treated with dasatinib. Blood 2008;112:abstract 3230.

12. Cole S, Kantarjian H, Ault P, Cortés JE. Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature. Clin Lymphoma Myeloma 2009;9:324-7.

13. Conchon M, Sanabani SS, Serpa M, Novaes MM, Nardinelli L, Ferreira PB, Dorliac PE, Bendit I. Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy. Adv Hematol 2010;2010:136252.

14. Tasigna (nilotinib) [package Insert]. East Hanover: Novartis Pharmaceuticals Corporation; 2007. Available from: https://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf. [Last accessed on 2015 Sep 30].

15. Conchon M, Sanabani SS, Bendit I, Santos FM, Serpa M, Dorliac-Llacer PE. Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study. J Hematol Oncol 2009;2:42.

16. Hochhaus A. Educational session: managing chronic myeloid leukemia as a chronic disease. Hematology Am Soc Hematol Educ Program 2011;2011:128-35.

17. Kuwabara A, Babb A, Ibrahim A, Milojkovic D, Apperley J, Bua M, Reid A, Foroni L, Rezvani K, Goldman J, Marin D. Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response. Blood 2010;116:1014-6.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/